Association between hemoglobin A1c variability and subclinical coronary atherosclerosis in subjects with type 2

Hae Kyung Yang1, Borami Kang1, Seung-Hwan Lee1

  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Insights

High hemoglobin A1c (HbA1c) variability, not just the average, is linked to coronary artery disease in type 2 diabetes patients. Stabilizing blood glucose may prevent early heart issues.

Area of Science:

  • Cardiology
  • Endocrinology
  • Diabetology

Background:

  • Type 2 diabetes (T2D) management often focuses on average blood glucose control.
  • However, blood glucose fluctuations (variability) may also impact cardiovascular health.
  • Subclinical coronary atherosclerosis is a key indicator of cardiovascular risk.

Purpose of the Study:

  • To investigate the association between hemoglobin A1c (HbA1c) variability and subclinical coronary atherosclerosis in individuals with T2D.
  • To determine if HbA1c variability is an independent risk factor for coronary artery disease in this population.

Main Methods:

  • Retrospective analysis of coronary computed tomography data from 595 T2D patients without prior cardiovascular disease.
  • Calculation of HbA1c variability metrics: intraindividual standard deviation (HbA1c-SD) and coefficient of variation (HbA1c-CV).
  • Definition of subclinical coronary atherosclerosis as a coronary calcium score >400.

Main Results:

  • Higher HbA1c variability (both HbA1c-SD and HbA1c-CV) was associated with a greater prevalence of subclinical coronary atherosclerosis.
  • This association remained significant even after adjusting for mean HbA1c levels in patients with diabetes duration of 10 years or less.
  • Odds ratios for subclinical coronary atherosclerosis were 2.894 for higher HbA1c-SD and 2.540 for higher HbA1c-CV.

Conclusions:

  • Long-term blood glucose stabilization is crucial for preventing subclinical coronary atherosclerosis in early-stage type 2 diabetes.
  • HbA1c variability is an important, independent predictor of coronary artery disease in T2D patients.
  • Clinical focus should include managing glucose fluctuations alongside average HbA1c levels.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
784
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
695